BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 21110239)

  • 1. Mesenchymal stem cells and innate tolerance: biology and clinical applications.
    Trento C; Dazzi F
    Swiss Med Wkly; 2010; 140():w13121. PubMed ID: 21110239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular and molecular interactions of mesenchymal stem cells in innate immunity.
    Spaggiari GM; Moretta L
    Immunol Cell Biol; 2013 Jan; 91(1):27-31. PubMed ID: 23146943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal stromal cells and hematopoietic stem cell transplantation.
    Bernardo ME; Fibbe WE
    Immunol Lett; 2015 Dec; 168(2):215-21. PubMed ID: 26116911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal stromal cells and the innate immune response.
    Le Blanc K; Davies LC
    Immunol Lett; 2015 Dec; 168(2):140-6. PubMed ID: 25982165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal stromal cells isolated from children with systemic juvenile idiopathic arthritis suppress innate and adaptive immune responses.
    Calkoen FG; Brinkman DM; Vervat C; van Ostaijen-Ten Dam MM; Ten Cate R; van Tol MJ; Ball LM
    Cytotherapy; 2013 Mar; 15(3):280-91. PubMed ID: 23312448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of the immunosuppressive effect of human adipose tissue-derived mesenchymal stromal cells through HLA-G1 expression.
    Yang HM; Sung JH; Choi YS; Lee HJ; Roh CR; Kim J; Shin M; Song S; Kwon CH; Joh JW; Kim SJ
    Cytotherapy; 2012 Jan; 14(1):70-9. PubMed ID: 21954834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro testing of immunosupressive effects of mesenchymal stromal cells on lymphocytes stimulated with alloantigens.
    Lysak D; Vlas T; Holubova M; Miklikova M; Jindra P
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Jun; 159(2):215-9. PubMed ID: 24077235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone Marrow Mesenchymal Stromal Cells from Patients with Acute and Chronic Graft-versus-Host Disease Deploy Normal Phenotype, Differentiation Plasticity, and Immune-Suppressive Activity.
    Copland IB; Qayed M; Garcia MA; Galipeau J; Waller EK
    Biol Blood Marrow Transplant; 2015 May; 21(5):934-40. PubMed ID: 25659882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stem cells and infectious diseases: Smarter than drugs.
    Mezey É; Nemeth K
    Immunol Lett; 2015 Dec; 168(2):208-14. PubMed ID: 26051681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immunomodulatory function of mesenchymal stem cells: mode of action and pathways.
    Uccelli A; de Rosbo NK
    Ann N Y Acad Sci; 2015 Sep; 1351():114-26. PubMed ID: 26152292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal stem cells as immunomodulator therapies for immune-mediated systemic dermatoses.
    Reddy BY; Xu DS; Hantash BM
    Stem Cells Dev; 2012 Feb; 21(3):352-62. PubMed ID: 21864110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal stromal cells for tissue-engineered tissue and organ replacements.
    Baiguera S; Jungebluth P; Mazzanti B; Macchiarini P
    Transpl Int; 2012 Apr; 25(4):369-82. PubMed ID: 22248229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunosuppression and mesenchymal stem cells: back to the future].
    Ménard C; Tarte K
    Med Sci (Paris); 2011 Mar; 27(3):269-74. PubMed ID: 21447296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Control of immune responses by mesenchymal stromal cells].
    Fibbe WE; Bernardo ME
    Rinsho Ketsueki; 2014 Oct; 55(10):2190-4. PubMed ID: 25297786
    [No Abstract]   [Full Text] [Related]  

  • 15. Mesenchymal stem cells for the treatment of neurological diseases: Immunoregulation beyond neuroprotection.
    Laroni A; de Rosbo NK; Uccelli A
    Immunol Lett; 2015 Dec; 168(2):183-90. PubMed ID: 26296458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunomodulation effects of mesenchymal stromal cells on acute graft-versus-host disease after hematopoietic stem cell transplantation.
    Zhao K; Lou R; Huang F; Peng Y; Jiang Z; Huang K; Wu X; Zhang Y; Fan Z; Zhou H; Liu C; Xiao Y; Sun J; Li Y; Xiang P; Liu Q
    Biol Blood Marrow Transplant; 2015 Jan; 21(1):97-104. PubMed ID: 25300866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoregulation by mesenchymal stem cells: biological aspects and clinical applications.
    Castro-Manrreza ME; Montesinos JJ
    J Immunol Res; 2015; 2015():394917. PubMed ID: 25961059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunosuppressive properties of mesenchymal stromal cells derived from amnion, placenta, Wharton's jelly and umbilical cord.
    Manochantr S; U-pratya Y; Kheolamai P; Rojphisan S; Chayosumrit M; Tantrawatpan C; Supokawej A; Issaragrisil S
    Intern Med J; 2013 Apr; 43(4):430-9. PubMed ID: 23176558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The (in) auspicious role of mesenchymal stromal cells in cancer: be it friend or foe.
    Kidd S; Spaeth E; Klopp A; Andreeff M; Hall B; Marini FC
    Cytotherapy; 2008; 10(7):657-67. PubMed ID: 18985472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosinergic Immunosuppression by Human Mesenchymal Stromal Cells Requires Co-Operation with T cells.
    Kerkelä E; Laitinen A; Räbinä J; Valkonen S; Takatalo M; Larjo A; Veijola J; Lampinen M; Siljander P; Lehenkari P; Alfthan K; Laitinen S
    Stem Cells; 2016 Mar; 34(3):781-90. PubMed ID: 26731338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.